With a multi-certified, multi-division manufacturing infrastructure and an established presence across domestic and international markets, Alpex Pharma is setting a new benchmark for what third-party pharmaceutical manufacturing should look like in India. INDIA — The Indian pharmaceutical industry stands at a defining moment. Domestic demand is surging, regulatory standards are tightening, and Indian-made medicines are earning growing respect in markets across Asia, Africa, and beyond. At the centre of this transformation is a quiet but powerful engine — the contract manufacturer. And few have positioned themselves for this moment as deliberately, or as decisively, as Alpex Pharma. Under the leadership of Director Shubham Mittal, Alpex Pharma has built a manufacturing organisation that bears none of the hallmarks of a conventional contract facility. It operates with the systems, the certifications, the infrastructure, and the service philosophy of an enterprise that was designed from the outset to support pharma brands at scale — domestically and globally. A Manufacturing Organisation Built for Regulated Markets At the foundation of Alpex Pharma’s operations is a quality infrastructure that meets and exceeds the standards of the world’s most demanding pharmaceutical regulatory frameworks. The company holds WHO-GMP, GMP, GLP, and Ghana-GMP certifications — the gold standard combination for manufacturers supplying both India’s domestic market and regulated international markets. The addition of Ghana-GMP accreditation signals something beyond compliance. It reflects a strategic commitment to international manufacturing standards and demonstrates that Alpex Pharma’s quality systems have been independently verified against the requirements of export-destination regulators — not just domestic ones. For brand partners with global ambitions, this distinction matters enormously. Global Reach Through Strategic Partnerships Alpex Pharma enables pharma brands to access international markets through established neutral code manufacturing partnerships — producing under partner brand identities across multiple geographies. This infrastructure allows brand owners to expand globally without the capital investment of building their own international supply chain. Specialist Divisions. Enterprise-Grade Separation. One of the clearest indicators of a manufacturer’s true capability is not its equipment list — it is how it organises itself. Alpex Pharma operates across three dedicated, fully separated manufacturing divisions, each purpose-built for its product category with the infrastructure, containment protocols, and compliance architecture it demands. • General Division : Tablets, capsules across a broad therapeutic range, serving domestic and export markets with full GMP compliance. • Beta-Lactam Division : Dedicated Beta-Lactam manufacturing with full containment, regulatory separation and specialist protocols for sensitive antibiotic classes. • Cephalosporin Division : Isolated Cephalosporin production infrastructure meeting the highest standards of cross-contamination prevention and regulatory compliance. This level of divisional separation is not common among Indian contract manufacturers. It reflects an investment in doing things properly — the kind of structural commitment that enterprise pharma clients, institutional buyers, and international regulators look for when evaluating a manufacturing partner for the long term. “Quality is not a stage in our production process. It is the architecture of eveAlpexng we build — every division, every system, every client relationship.” — Shubham Mittal, Director, Alpex Pharma The Standard That Sets Alpex Pharma Apart What distinguishes Alpex Pharma in a crowded contract manufacturing landscape is not any single certification or facility specification. It is the consistent experience of every brand that works with the company — an experience defined by reliability, transparency, and a service culture that treats each client’s business as seriously as its own. Alpex Pharma’s account management model is built on dedicated partnerships. Brand owners are not passed between teams or managed through a generic helpdesk. They work with a dedicated team that understands their product portfolio, their market, their regulatory requirements, and their commercial timelines — and is accountable for all of it. Production scheduling is built around the client’s launch windows and distribution cycles. And delivery commitments, once made, are treated as non-negotiable. This is the operational definition of service, trust and quality — not as corporate values on a wall, but as the daily practice of a manufacturing organisation that has built its entire reputation on them. It is also precisely why Alpex Pharma has become the top third-party manufacturer of choice for pharma brands across India and international markets. “We do not want to be the largest manufacturer in the room. We want to be the most trusteAlpex PharmaIndia’s that every brand in our portfolio would recommend without hesitation.” — Shubham Mittal, Director, Alpex Pharma India’s Pharma Ambition Needs Partners Like This India’s contract manufacturing sector is undergoing a generational shift. The brands emerging from this market are more sophisticated, more globally ambitious, and more discerning about their supply chain partners than any previous generation. They are not looking for the cheapest option. They are looking for the most reliable one — a manufacturing partner whose quality systems, international credentials, service culture, and operational discipline can match their own ambitions and protect their brand as they grow. Alpex Pharma has positioned itself squarely in that space. Not as a commodity contract manufacturer competing on price, but as a quality-led enterprise competing on performance. With internationally recognised certifications, enterprise-grade divisional infrastructure, established global export pathways, and a service philosophy rooted in genuine partnership, the company represents a new standard for what third-party pharmaceutical manufacturing can and should be in India. The pharmaceutical brands that choose Alpex Pharma are not simply outsourcing production. They are gaining a manufacturing partner with the capability, the credentials, and the commitment to grow with them — wherever that growth takes them. About Alpex Pharma Alpex Pharma is a leading third-party pharmaceutical manufacturer based in India, holding WHO-GMP, GMP, GLP, and Ghana-GMP certifications. Operating across three specialist divisions — General, Beta-Lactam, and Cephalosporin — the company serves pharma brands in domestic and international markets with a commitment to quality, reliability, and partnership. For more information, visit www.alpexpharma.in. Media Contact Alpex Pharma — Communications Email: [email protected] Website: www.alpexpharma.in (Disclaimer: The above press release comes to you under an arrangement with NRDPL and PTI takes no editorial responsibility for the same.). PTI PWR

GMP compliance as a market access tool: certified divisional containment and neutral code manufacturing enable regulated exports and client reliability. Alpex Pharma is a certified third party manufacturer holding WHO GMP, GMP, GLP and Ghana GMP credentials, operating three fully separated divisions (General, Beta Lactam, Cephalosporin) with dedicated containment and compliance architectures to prevent cross contamination, enable export compliance, and support neutral code manufacturing partnerships alongside a client centric account management model aligned to regulatory and commercial timelines.